5-Chloro-3-fluorobenzene-1,2-diamine, 95.0%, 1g

Methyl 2-amino-5-methylnicotinate, 95.0%, 250mg

10-Methyl-3,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-10H-phenothiazine, 98%, 100mg

Nickel iodide,99%, 99%, 1g

(2-(Difluoromethyl)pyridin-4-yl)boronic acid, 97%, 50mg

Methyl 1H-imidazo[4,5-b]pyridine-6-carboxylate, 95.0%, 250mg

(R)-2-((6-(3-((3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile, 98%, 50mg

6-Bromo-1-(phenylsulfonyl)-1H-pyrrolo[3,2-b]pyridine, 98%, 10g

myo-Inositol>99.0%(GC)500g

4-oxo-1,4-dihydroquinazoline-2-carboxylic acid, 250mg

4,4'-(Cyclohexane-1,1-diyl)bis(2-cyclohexylphenol), 98%, 1g

Long working distance plan phase 40x/0.65 IOS objective, working distance 2.74 mm

(S)-2-(Dimethylamino)propan-1-ol, 98%, 250mg